Tandem peptide epitopes facilitate CD4-dependent activation of T cell clones

Immunology and Cell Biology

Volumn 75, Issue 2, 1997, Pages 148-153

  Hayball, John D ^a   Fidler, Sarah J ^a   Palliser, Deborah ^a   Rees, Ann D M ^a   Lamb, Jonathan R ^a   Lake, Richard A ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

dimer of heterodimers; human immunodeficiency virus; linked epitopes; major histocompatibility complex class II

Indexed keywords

CD4 ANTIGEN; DIMER; EPITOPE; HLA ANTIGEN CLASS 2; HLA DR1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOMER;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; T LYMPHOCYTE ACTIVATION; TANDEM REPEAT;

EID: 0030966106     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1997.20     Document Type: Article

References (30)

1. Germain RN, Margulies DH. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 1993; 11: 403-50.
2. Cresswell P. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 1994; 12: 259-93.
3. Todd JA, Acha-Orbea H, Bell JI et al. A molecular basis for MHC class II-associated autoimmunity (erratum in Science 1988; 241:888). Science 1988; 240: 1003-9.
4. Rudensky A, Preston HP, Hong SC, Barlow A, Janeway CJ. Sequence analysis of peptides bound to MHC class II molecules (comments). Nature 1991; 353: 622-7.
5. Hunt DF, Michel H, Dickinson TA et al. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science 1992; 256: 1817-20.
6. Chicz RM, Urban RG, Gorga JC, Vignali DA, Lane WS, Strominger JL. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 1993; 178: 27-47.
7. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell 1994; 76: 263-74.
8. Symer DE, Dintzis RZ, Diamond DJ, Dintzis HM. Inhibition or activation of human T cell receptor transfectants is controlled by defined, soluble antigen arrays. J. Exp. Med. 1992; 176: 1421-30.
9. Kupfer A, Singer SJ, Janeway CJ, Swain SL. Coclustering of CD4 (L3T4) molecule with the T-cell receptor is induced by specific direct interaction of helper T cells and antigen-presenting cells. Proc. Natl Acad. Sci. USA 1987; 84: 5888-92.
10. Dianzani U, Shaw A, al Ramadi B, Kubo RT, Janeway CJ. Physical association of CD4 with the T cell receptor. J. Immunol. 1992; 148: 678-88.
11. Cammarota G, Scheirle A, Takacs B et al. Identification of a CD4 binding site on the beta-2 domain of HLA-DR molecules. Nature 1992; 356: 799-801.
12. Konig R, Huang LY, Germain RN. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature 1992; 356: 796-8.
13. + single transgenic mice. J. Immunol. 1991; 146: 854-9.
14. Konig R, Shen X, Germain RN. Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J. Exp. Med. 1995; 182: 779-87.
15. Viellette A, Bookman MA, Horack EM, Bolen JB. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell 1988; 55: 301-8.
16. Brown JH, Jardetzky TS, Gorga JC et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 (comments). Nature 1993; 364: 33-9.
17. Schafer PH, Pierce SK. Evidenee for dimers of MHC class II molecules in B lymphocytes and their role in low affinity T cell responses. Immunity 1994; 1: 699-707.
18. Busch R, Hill CM, Hayball JD, Lamb JR, Rothbard JB. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding. J. Immunol. 1991; 147: 1292-8.
19. Fernandez MH, Faith A, Higgins JA, Weber J, Rees AD. The effect of a single amino acid substitution within the V3 loop of HIV-1 gp120 on HLA-DR1-restricted CD4T-cell recognition. Immunology 1995; 85: 176-83.
20. Wilks D, Walker L, O'Brien J, Habeshaw J, Dalgleish A. Differences in affinity of anti-CD4 monoclonal antibodies predict their effects on syncytium induction by human immunodeficiency virus. Immunology 1990; 71: 10-15.
21. Helbert MR, L'age SJ, Mitchison NA. Antigen presentation, loss of immunological memory and AIDS (review). Immunol. Today 1993; 14: 340-4.
22. Meyaard L, Schuitemaker H, Miedema F. T-cell dysfunction in HIV infection: Anergy due to defective antigen-presenting cell function? (review). Immunol. Today 1993; 14: 161-4.
23. Fidler SJ, Dorrell L, Ball S et al. An early antigen presenting cell defect in HIV-1 infected patients correlates with CD4 dependency in human T cell clones. Immunology 1996; 89: 46-53.
24. Kozono H, White J, Clements J, Marrack P, Kappler J. Production of soluble MHC class II proteins with covalently bound single peptides. Nature 1994; 369: 151-4.
25. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984; 312: 763-6.
26. Clayton LK, Sieh M, Pious DA, Reinherz EL. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. Nature 1989; 339: 548-51.
27. Linette GP, Hartzman RJ, Ledbetter JA, June CH. HIV-1-infceted T cells show a selective signaling defect after perturbation of CD3/antigen receptor. Science 1988; 241: 573-6.
28. Heath SL, Tew JG, Szakal AK, Burton GF. Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 1995; 377: 740-4.
29. + T cells. J. Exp. Med. 1995; 182: 2045-56.
30. Frankel SS, Wenig BM, Burke AP et al. Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 1996; 272: 115-17.